News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
366,002 Results
Type
Article (14465)
Company Profile (114)
Press Release (351423)
Multimedia
Podcasts (38)
Webinars (7)
Section
Business (112652)
Career Advice (456)
Deals (18620)
Drug Delivery (29)
Drug Development (31190)
Employer Resources (50)
FDA (8795)
Job Trends (7678)
News (172792)
Policy (12358)
Tag
Academia (1323)
Accelerated approval (3)
Allergies (42)
Alliances (34845)
ALS (27)
Alzheimer's disease (519)
Antibody-drug conjugate (ADC) (81)
Approvals (8829)
Artificial intelligence (254)
Autoimmune disease (5)
Automation (13)
Bankruptcy (131)
Best Places to Work (6524)
BIOSECURE Act (7)
Biosimilars (10)
Biotechnology (86)
Bladder cancer (31)
Brain cancer (13)
Breast cancer (124)
Cancer (1089)
Cardiovascular disease (68)
Career advice (408)
Career pathing (9)
CAR-T (110)
Cell therapy (283)
Cervical cancer (11)
Clinical research (24565)
Collaboration (633)
Compensation (118)
Complete response letters (3)
COVID-19 (1148)
CRISPR (41)
C-suite (153)
Cystic fibrosis (47)
Data (1059)
Decentralized trials (1)
Denatured (18)
Depression (17)
Diabetes (110)
Diagnostics (4929)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (77)
Drug pricing (14)
Drug shortages (4)
Duchenne muscular dystrophy (26)
Earnings (38954)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51583)
Executive appointments (422)
FDA (9521)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (498)
Gene editing (94)
Generative AI (24)
Gene therapy (184)
GLP-1 (232)
Government (1235)
Grass and pollen (2)
Guidances (84)
Healthcare (9896)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Indications (13)
Infectious disease (1226)
Inflammatory bowel disease (67)
Inflation Reduction Act (3)
Influenza (33)
Intellectual property (65)
Interviews (52)
IPO (8018)
IRA (8)
Job creations (1436)
Job search strategy (362)
Kidney cancer (4)
Labor market (10)
Layoffs (120)
Leadership (3)
Legal (2521)
Liver cancer (36)
Lung cancer (130)
Lymphoma (67)
Machine learning (7)
Management (17)
Manufacturing (198)
MASH (16)
Medical device (11508)
Medtech (11513)
Mergers & acquisitions (10971)
Metabolic disorders (226)
Multiple sclerosis (30)
NASH (3)
Neurodegenerative disease (32)
Neuropsychiatric disorders (4)
Neuroscience (723)
NextGen: Class of 2025 (3535)
Non-profit (1524)
Now hiring (9)
Obesity (95)
Opinion (77)
Ovarian cancer (41)
Pain (53)
Pancreatic cancer (42)
Parkinson's disease (68)
Partnered (12)
Patents (155)
Patient recruitment (59)
Peanut (26)
People (32817)
Pharmaceutical (16)
Phase I (9060)
Phase II (11081)
Phase III (7187)
Pipeline (652)
Policy (32)
Postmarket research (501)
Preclinical (4111)
Press Release (66)
Prostate cancer (46)
Psychedelics (4)
Radiopharmaceuticals (156)
Rare diseases (138)
Real estate (3365)
Recruiting (20)
Regulatory (9422)
Reports (18)
Research institute (1270)
Resumes & cover letters (68)
Rett syndrome (4)
RNA editing (2)
RSV (23)
Schizophrenia (13)
Series A (90)
Series B (55)
Service/supplier (7)
Sickle cell disease (19)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (13)
Startups (2508)
State (2)
Stomach cancer (2)
Supply chain (27)
Tariffs (6)
The Weekly (19)
Vaccines (327)
Venture capitalists (19)
Weight loss (35)
Women's health (18)
Worklife (2)
Date
Today (16)
Last 7 days (464)
Last 30 days (1550)
Last 365 days (16932)
2025 (6062)
2024 (18727)
2023 (22102)
2022 (30827)
2021 (32521)
2020 (30547)
2019 (25800)
2018 (19461)
2017 (18871)
2016 (17762)
2015 (20560)
2014 (15177)
2013 (12744)
2012 (13781)
2011 (14066)
2010 (12828)
Location
Africa (318)
Alabama (42)
Alaska (6)
Arizona (125)
Arkansas (10)
Asia (24124)
Australia (4195)
California (3100)
Canada (1080)
China (256)
Colorado (174)
Connecticut (133)
Delaware (49)
Europe (49314)
Florida (510)
Georgia (141)
Idaho (33)
Illinois (294)
India (13)
Indiana (169)
Iowa (5)
Japan (125)
Kansas (85)
Kentucky (7)
Louisiana (7)
Maine (20)
Maryland (478)
Massachusetts (2153)
Michigan (189)
Minnesota (261)
Mississippi (2)
Missouri (62)
Montana (24)
Nebraska (15)
Nevada (25)
New Hampshire (67)
New Jersey (962)
New Mexico (16)
New York (904)
North Carolina (550)
North Dakota (8)
Northern California (1177)
Ohio (106)
Oklahoma (11)
Oregon (20)
Pennsylvania (629)
Puerto Rico (11)
Rhode Island (25)
South America (507)
South Carolina (23)
South Dakota (1)
Southern California (1272)
Tennessee (64)
Texas (500)
United States (12208)
Utah (114)
Virginia (60)
Washington D.C. (13)
Washington State (346)
West Virginia (3)
Wisconsin (41)
366,002 Results for "lgc biosearch technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Arbor Biosciences and LGC, Biosearch Technologies Partner on Marker Discovery and Genotyping in Agrigenomics
Arbor Biosciences announced a partnership with Biosearch Technologies, the complete genomics portfolio of LGC Group.
January 30, 2020
·
3 min read
OliX Pharmaceuticals Signs Agreement with LGC Biosearch Technologies to Accelerate Production of Asymmetric siRNA for the Treatment of Sub-Retinal Fibrosis and Wet Macular Degeneration
OliX Pharmaceuticals, Inc. announced that the Company signed an exclusive contract with LGC Biosearch Technologies Inc., a contract development and manufacturing organization and part of the global life sciences tools company headquartered in London, to scale production of OliX’s OLX301D therapeutic candidate.
June 16, 2020
·
3 min read
LGC’s ValuPanel Reagents help public laboratories detect SARS-CoV-2 and influenza
LGC, Biosearch Technologies today announces the release of a new set of ValuPanel™ Reagents to help the efforts of public health laboratories to detect SARS-CoV-2, influenza A, and influenza B.
February 2, 2021
·
3 min read
Novel enzyme from LGC, Biosearch Technologies is fast and specific, even at room temperature
LGC, Biosearch Technologies proudly introduces RapiDxFire™ Thermostable RT, a truly thermostable reverse transcriptase designed specifically to meet the needs of diagnostic kit developers.
March 8, 2019
·
2 min read
Business
LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications
LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.
October 24, 2018
·
3 min read
OliX Pharmaceuticals Signs Agreement with LGC Biosearch Technologies to Accelerate Production of Asymmetric siRNA for the Treatment of Androgenic Alopecia
OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), announced that the companies signed an exclusive contract to scale production of OliX’s OLX104C, an investigational RNAi therapeutic in development for the treatment of androgenic alopecia.
June 9, 2021
·
3 min read
Deals
U.S. Alliance Pharma Acquires U.K.-based LGC’s Drug Development Solutions (DDS) Business
Alliance Pharma, a U.S. leader in small and large molecule bioanalytical services in the pharmaceutical and biopharmaceutical industry, closed on the purchase of Drug Development Solutions, a U.K.-based bioanalytical and material science testing contract research organization, from LGC.
July 13, 2022
·
4 min read
Business
Swift Biosciences and LGC Partner on Targeted Sequencing Assays for AgBio Market
ANN ARBOR, Mich. , Feb. 24, 2020 /PRNewswire/ -- Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), today announced a partnership agreement with LGC, Biosearch Technologies, a global leader in specialty genomic analysis tools to leverage Swift’s targeted sequencing technology into LGC Biosearch T
February 24, 2020
·
4 min read
Deals
Ampersand-backed Alliance Pharma to acquire LGC’s Drug Development Solutions Business (“DDS”) and welcomes KKR as joint shareholder
Alliance Pharma, a US-based Bioanalytical CRO and an Ampersand portfolio company, has agreed to acquire DDS, a UK-based Bioanalytical Business Unit of LGC.
May 17, 2022
·
5 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
1 of 36,601
Next
